These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5144532)

  • 21. The treatment of operable cancer of the breast: A clinical trial in the South-East region of Scotland.
    Hamilton T; Langlands AO; Prescott RJ
    Br J Surg; 1974 Oct; 61(10):758-61. PubMed ID: 4416550
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of survival in a sample of patients treated with radical mastectomy for mammary carcinoma].
    Abeatici S; Sera G; Palestini N
    Minerva Chir; 1979 Jan 15-31; 34(1-2):39-48. PubMed ID: 481761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the contralateral breast after mastectomy for unilateral carcinoma.
    Herrmann JB
    Surg Gynecol Obstet; 1973 May; 136(5):777-9. PubMed ID: 4701910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rapidly growing breast cancer: results of a retrospective analysis with a study of prognostic factors].
    Chevallier B; Asselain B; Kunlin A; Veyret C; Bastit P
    Bull Cancer; 1986; 73(2):139-47. PubMed ID: 3730634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Infiltrating lobular carcinoma of the breast. Clinical picture, treatment and prognosis].
    Stelmach A; Ryś J; Mituś J; Skotnicki P; Reinfuss M
    Ginekol Pol; 1998 Jan; 69(1):2-5. PubMed ID: 9553314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis based on primary breast carcinoma instead of pathological nodal status.
    Ménard S; Bufalino R; Rilke F; Cascinelli N; Veronesi U; Colnaghi MI
    Br J Cancer; 1994 Oct; 70(4):709-12. PubMed ID: 7917924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.
    Koca B; Kuru B; Karabicak I; Yürüker SS; Ozen N
    Ann Ital Chir; 2014; 85(3):249-53. PubMed ID: 25074433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of patients with relapsing breast cancer: analysis of 302 patients.
    Lionetto R; Pronzato P; Bertelli GF; Ardizzoni A; Conte PF; Rosso R
    Oncology; 1986; 43(5):278-82. PubMed ID: 3763121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
    Winstanley J; Cooke T; George WD; Murray G; Holt S; Croton R; Griffiths K; Nicholson R
    Br J Cancer; 1991 Jul; 64(1):99-101. PubMed ID: 1854633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer.
    Baker RR; Montague AC; Childs JN
    Ann Surg; 1979 May; 189(5):553-9. PubMed ID: 443908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis of patients with unilateral and bilateral primary breast cancer in Northeast China.
    Xing Y; Meng Q; Sun L; Chen X; Cai L
    Breast Cancer; 2015 Sep; 22(5):536-43. PubMed ID: 24510639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.
    Yoshida A; Takahashi O; Okumura Y; Arima N; Nakatsukasa K; Tanabe M; Shien T; Masuda N; Tanaka S; Komoike Y; Taguchi T; Iwase T; Nishimura R; Inaji H; Yamauchi H; Ishitobi M;
    Eur J Surg Oncol; 2016 Apr; 42(4):474-80. PubMed ID: 26853760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time since childbirth and prognosis in primary breast cancer: population based study.
    Kroman N; Wohlfahrt J; Andersen KW; Mouridsen HT; Westergaard T; Melbye M
    BMJ; 1997 Oct; 315(7112):851-5. PubMed ID: 9353505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data.
    Tubtimhin S; Promthet S; Suwanrungruang K; Supaattagorn P
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3167-3174. PubMed ID: 30486605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical results of a radiotherapy-surgery program analyzed in relation to risk factors in cancer of the breast].
    Micheletti E; Plebani F
    Radiol Med; 1986; 72(1-2):43-8. PubMed ID: 3961215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy.
    Lee DS; Kim SH; Suh YJ; Kim S; Kim HK; Shim BY
    Jpn J Clin Oncol; 2011 Jul; 41(7):854-66. PubMed ID: 21719749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of exclusive skeletal metastases in stage IV primary carcinoma of the breast.
    Chiedozi LC
    Surg Gynecol Obstet; 1988 Oct; 167(4):303-6. PubMed ID: 3420504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.
    Span PN; Tjan-Heijnen VC; Manders P; Beex LV; Sweep CG
    Oncogene; 2003 Jul; 22(31):4898-904. PubMed ID: 12894232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.